Hormone Therapy for Menopause: A Shift in Perspective?
The FDA is considering changes to the strictest warning labels on hormone replacement therapies for menopause symptoms. This move comes after years of debate over the risks and benefits of these treatments. The current black box warning, the most severe type of alert, has been in place since 2003.